1.11
price down icon6.72%   -0.08
after-market Handel nachbörslich: 1.11
loading

Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.11%
28.03
23.15 18.67 15.89 16.96
Operating Income/Loss
21.11%
-28.03
-23.15 -18.67 -15.89 -16.96
Income/Loss From Continuing Operations Before Tax
19.92%
-25.05
-20.89 -16.45 -14.49 -15.85
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.92%
-25.05
-20.89 -16.45 -14.49 -15.85
Net Income/Loss
19.92%
-25.05
-20.89 -16.45 -14.49 -15.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
199.19%
1.1681
-1.1775 -1.7849 - 4.1304
Basic Earnings Per Share
8.51%
-0.51
-0.47 -0.37 -0.37 -0.45
Diluted Earnings Per Share
8.51%
-0.51
-0.47 -0.37 -0.37 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):